GlassScriptPhysician profile
Jaime Gish
NPI 1932598117
$2,332.10
in general payments reported to CMS, 2019-2025
16 companies · $640 in 2025
The $640 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.54 · 2022: $223 · 2023: $639 · 2024: $731 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495 · Education: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.92 |
| Education | $514.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $828.92 | 2021-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $402.64 | 2022-2025 | Sotyktu |
| Abbvie INC. | $327.92 | 2022-2025 | |
| Ucb, INC. | $190.95 | 2022-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $186.81 | 2021-2025 | |
| Hill Dermaceuticals, INC. | $90.49 | 2025 | Tolak |
| Regeneron Healthcare Solutions, INC. | $79.38 | 2021-2025 | Dupixent |
| Amgen INC. | $77.34 | 2023-2025 | Otezla, Otezla |
| Lilly USA, LLC | $26.35 | 2021-2022 | |
| Genzyme Corporation | $26.08 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $25.78 | 2021-2022 | |
| Pfizer INC. | $15.40 | 2025 | |
| Organogenesis INC. | $14.95 | 2025 | Puraply Wound Matrix |
| Dermavant Sciences, INC. | $13.51 | 2022 | |
| Galderma Laboratories, L.P. | $13.07 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Gish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.